• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

HPV vaccine effective against infection and for herd immunity

byKate AndersonandCordelia Ross
January 22, 2019
in Infectious Disease, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Human papillomavirus (HPV) vaccine decreased infection rates among vaccinated women by 70-80%, depending on vaccine type

2. Infection with 4-valent vaccine-type HPV among unvaccinated women also decreased by about 40%.

Study Rundown: Current literature suggests HPV infection is linked to several types of female and male genital, anal, and oropharyngeal cancers. Previous studies have demonstrated the efficacy of the 3 HPV vaccines licensed in the United States in reducing vaccine-type HPV in the community, however the impact on herd immunity is unclear. Researchers in this study analyzed genotype data on HPV infection in vaccinated and unvaccinated women during the 11-year period after the first vaccine was released in the US (2006 to 2017). They sought to evaluate the effectiveness and herd protection of the 4-valent and 9-valent HPV vaccines, which prevent 4 and 9 cancer-causing strains of HPV, respectively. Results showed that the odds of infection with 4-valent and 9-valent vaccine-type HPV at the end of the study period were about 1/10 and 1/5 times the odds of infection at the beginning of the study. While the odds of infection with 4-valent vaccine-type HPV among unvaccinated women decreased by 50% over the study period, the odds of infection with 9-valent vaccine-type HPV did not change significantly in this population. Vaccine rates increased by about 85%, and the study found overall 4-valent vaccine rates of >95% by the end of the study. This study is limited by the restricted geographical recruitment region and the small number of participants who received the 9-valent HPV vaccine. Nonetheless, these findings suggest the 4-valent vaccine is effective in reducing 4-valent vaccine-type HPV infection rates among vaccinated and unvaccinated women, and pediatricians should continue to educate patients on the benefits of these vaccinesContinued surveillance is required to study the longevity of vaccine effectiveness and effects of the 9-valent vaccine on infection rates.

Click to read the study, published today in Pediatrics

Recommended reading: HPV infection rates in men

In-depth [surveillance study]: In this study, researchers analyzed surveillance data collected from one major U.S. city during 4 one-year waves between 2006 and 2017 to determine the proportion of vaccinated and unvaccinated women aged 13 to 26 years (N=1580, 72.8% African American/multiracial, 26.8% white) who were vaccine-type HPV positive (4-valent, 9-valent, or 5 additional strains not covered by the 9-valent vaccine). Results showed 80.6% participants reported ≥2 male sexual partners in their lifetime, and 16.9% reported their age of first sexual encounter to be ≤13 years. Rates of HPV vaccination (receipt of ≥ 1 dose with either vaccine) rose consistently between each wave, from 0% during the 1st wave to 84.3% in wave 4. By the end of the study, 97% of participants had received the 4-valent vaccine. The odds of infection with 4-valent and 9-valent vaccine-type HPV decreased significantly among vaccinated women (adjusted odds ratio [aOR] 0.13 and 0.18, respectively) between wave 1 and wave 4. The odds of infection with 4-valent vaccine-type HPV decreased significantly among unvaccinated women (aOR 0.50) but infection with 9-valent vaccine-type HPV did not change significantly. The odds of infection with ≥1 of the 5 additional HPV types in the 9-valent vaccine decreased significantly among vaccinated women (aOR 0.26) but increased significantly among unvaccinated women (aOR 1.90) between wave 1 and wave 4.

Image: PD

RELATED REPORTS

Human papillomavirus (HPV) vaccination rates have increased in recent years

Human papillomavirus vaccine effective in preventing infections in the United States

Imiquimod noninferior to surgery in management of vulvar high-grade squamous intraepithelial lesions

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hpv vaccinehuman papillomavirus (HPV)vaccination
Previous Post

The DETECTIVE trial: tafenoquine reduces risk of Plasmodium vivax relapse

Next Post

Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

RelatedReports

Mental health parity law associated with financial protection for children
Chronic Disease

Human papillomavirus (HPV) vaccination rates have increased in recent years

June 23, 2022
Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
Chronic Disease

Imiquimod noninferior to surgery in management of vulvar high-grade squamous intraepithelial lesions

May 17, 2022
Preterm infants responsive to PCV13 vaccine
Infectious Disease

Inactivated, adjuvant enterovirus 71 vaccine is safe and effective against fatal enterovirus infections in children aged 2-71 months

May 10, 2022
Next Post
Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

Aspirin therapy linked to fewer cases of preeclampsia

Aspirin use associated with reduction in cardiovascular events but increase in bleeding risk

Solitary kidney not associated with contrast-induced nephropathy

Robust survival benefit seen in lupus nephritis patients receiving renal transplant

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Treatment of anal high-grade squamous intraepithelial lesions can reduce rates of progression to invasive anal cancer.
  • High tumour mutation burden in NSCLC associated with improved clinical outcomes of PD-L1 blockade across PD-L1 expression subgroups
  • Subsidization of supermarkets may help reduce obesity risk in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.